Yield10 Bioscience Revenue 2011-2026 | YTEN

Company revenue is the total amount of money received from the sale of goods or services over a certain period of time. It is one of the key indicators of a company's financial condition and success.

Traditionally defined as follows:
Revenue = Price * Quantity of products

Revenue is one of the components of a company’s income. In international practice, revenue is understood as the inflow or other increase in a company's assets or the settlement of its obligations that occurs as a result of the company’s core or main activity.^[1]

This is an important indicator for assessing the financial condition and efficiency of a company. It makes it possible to determine how successfully a company sells its products or services on the market. In addition, revenue can be used to calculate other financial indicators such as profit, profitability, and market share.

Various factors can influence this indicator, including demand for goods or services, market competition, economic conditions, and the company's marketing efforts. Therefore, its analysis and monitoring are important tasks for the successful development of a business.

Annual Revenue Yield10 Bioscience

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
60 K	450 K	614 K	799 K	806 K	556 K	944 K	1.16 M	2.59 M	2.8 M	5.39 M	42.3 M	1.42 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
42.3 M	60 K	4.61 M

Quarterly Revenue Yield10 Bioscience

2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
450 K	300 K	-	-	-	60 K	-	111 K	103 K	149 K	-	92 K	174 K	196 K	-	204 K	221 K	179 K	-	224 K	318 K	124 K	-	76 K	285 K	60 K	-	223 K	293 K	324 K	-	473 K	188 K	157 K	496 K	327 K	744 K	645 K	856 K	632 K	699 K	613 K	746 K	629 K	1.71 M	1.94 M	1.4 M	674 K	923 K	42.3 M	439 K	469 K	191 K	326 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
42.3 M	60 K	1.4 M

References

Adhikari, B. (2010). Impact of Revenue Planning In Nepal Investment Bank Limited (Doctoral dissertation, Faculty of Management).

Revenue of other stocks in the Agricultural inputs industry

Issuer	Revenue	Price	% 24h	Market Cap	Country
Акрон AKRN	179 B	-	-	-	Russia
Corteva CTVA	17.4 B	$ 80.05	1.28 %	$ 54.4 B	USA
ФосАгро PHOR	440 B	-	-	-	Russia
China Green Agriculture CGA	75.3 M	-	0.51 %	$ 27.6 M	China
CF Industries Holdings CF	7.08 B	$ 123.29	0.78 %	$ 20 B	USA
FMC Corporation FMC	1.22 B	$ 14.26	3.33 %	$ 1.78 B	USA
ICL Group Ltd ICL	7.15 B	$ 5.38	0.94 %	$ 7.83 B	Israel
American Vanguard Corporation AVD	515 M	$ 3.5	-14.0 %	$ 99.5 M	USA
Bioceres Crop Solutions Corp. BIOX	335 M	$ 0.42	-4.27 %	$ 435 M	Argentina
Intrepid Potash IPI	298 M	$ 41.94	0.79 %	$ 546 M	USA
The Scotts Miracle-Gro Company SMG	3.41 B	$ 62.25	0.14 %	$ 3.59 B	USA
Nutrien Ltd. NTR	20.9 B	$ 79.55	2.26 %	$ 34.8 B	Canada
Origin Agritech Limited SEED	46.4 M	$ 1.23	-4.65 %	$ 6.91 M	China
Marrone Bio Innovations MBII	44.3 M	-	-5.9 %	$ 180 M	USA
Arcadia Biosciences RKDA	5.33 M	$ 1.72	-2.27 %	$ 2.13 M	USA
The Mosaic Company MOS	11.1 B	$ 28.83	4.19 %	$ 9.22 B	USA
CVR Partners, LP UAN	606 M	$ 128.99	-1.83 %	$ 1.36 B	USA